Dr. Nabila A. Dahodwala, MD

Dr. Dahodwala practices at Pennsylvania Hospital in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Dahodwala's NPI, 1083815732, was assigned on May 30, 2007. Dr. Dahodwala graduated from Columbia University College of Physicians and Surgeons in 2002. Dr. Dahodwala holds Pennsylvania license MD429210.

Dr. Dahodwala's primary practice is Pennsylvania Hospital, at 800 Spruce Street, Philadelphia, PA 19107 in Philadelphia County. The practice phone is (215) 829-3000.

Dr. Dahodwala's primary practice is Pennsylvania Hospital in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Dahodwala is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Dahodwala to 2 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dahodwala practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Dahodwala's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Dahodwala is licensed in Pennsylvania.

CMS data shows 246 Medicare services from Dr. Dahodwala across 3 procedure codes in 2024, for 148 Medicare patients. Medicare paid $11,995 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 148 Medicare patients who saw Dr. Dahodwala in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dahodwala's median patient age at 69, with 50% women.

In 2024, Dr. Dahodwala wrote 633 Medicare Part D claims for 108 patients. 84% of them were for generic drugs. CMS names the drug for 513 of them, across 16 drugs with 11 or more claims each, at $203,486 in total drug cost. In 2023, CMS named 335 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Dahodwala for performance year 2024, reported as part of a group. Dr. Dahodwala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dahodwala as offering telehealth.

Dmand AI links 71 papers to Dr. Dahodwala, published from 2012 to 2025. 2016 was the busiest year, with 8. The most frequent topics are Parkinson Disease, Neuropsychological Tests and Caregivers. Dr. Dahodwala has published most often in J Parkinsons Dis. Dr. Dahodwala's most frequent co-authors are Daniel Weintraub, MD, John Eric Duda, MD and James Morley, MD.

CMS Open Payments shows 20 general payments to Dr. Dahodwala from 6 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 59% of the total. Genentech, Inc. paid the most, $2,480. It also lists 2 research payments totaling $453 from 2020 to 2021.

Dr. Dahodwala graduated from Columbia University College of Physicians and Surgeons in 2002.